nadim: baseline ctdna as a prognostic factor for pfs
Published 3 years ago • 99 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
3:44
ctdna as a diagnostic, prognostic, and predictive biomarker for lung cancer
-
1:27
pre-treatment ctdna levels significantly predicts os and pfs in nadim ii
-
1:02
galaxy: ctdna as a prognostic biomarker in resected colorectal cancer
-
6:55
the prognostic value of ctdna in nsclc treated with neoadjuvant chemoimmunotherapy
-
3:29
ctdna and cfdna : prognostic value in the neoadjuvant setting of colon cancer
-
1:19
ctdna as a biomarker for post-resection colorectal cancer recurrence
-
4:25
technical considerations for ctdna testing in nsclc
-
2:40
profiling circulating tumor dna to monitor and classify brain lymphomas
-
3:44
evaluating the use of ctdna as a biomarker in lung cancer
-
3:30
ctdna as an mrd biomarker for nsclc
-
1:33
circulating tumor hpv-dna as a prognostic marker for patients with oropharyngeal cancer
-
3:25
understand ctdna testing
-
1:49
circulating tumor dna as a biomarker in multiple myeloma: pitfalls and future outlooks
-
1:09
ctdna mrd as a biomarker for solid tumors
-
0:44
ctdna and immunoscore as prognostic markers in stage iii colon cancer
-
46:53
ctdna and mrd: who, when, and then what? | 2022 evolution conference
-
3:32
the role of ctdna in lung cancer screening
-
58:52
ctdna and mrd | 2023 best of gi cancer conference
-
1:05:21
ctdna and mrd testing | colorectal cancer care tools for surveillance